Alexander J. Lazar

142.1k citations

448 papers · 21.1k indexed · 7 hit papers · h-index 77

Oncology top 0.1%
- Vascular Tumors and Angiosarcomas 61
- Cutaneous Melanoma Detection and Management 38
Pulmonary and Respiratory Medicine top 0.05%
- Sarcoma Diagnosis and Treatment 225
Rheumatology top 0.1%
- Soft tissue tumor case studies 48
Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 49
Pathology and Forensic Medicine top 0.1%
Cardiology and Cardiovascular Medicine
- Cardiac tumors and thrombi 56
Molecular Biology
- Melanoma and MAPK Pathways 40
Gastroenterology
- Gastrointestinal Tumor Research and Treatment 34

Co-authors: Dina Lev Wei‐Lien Wang Raphael E. Pollock Dolores López‐Terrada Jeffrey E. Gershenwald Elizabeth G. Demicco Michael A. Davies Víctor G. Prieto
Cited by: Oncology Pulmonary and Respiratory Medicine Rheumatology
Journals: Journal of Clinical Oncology (42 papers)Clinical Cancer Research (27 papers)Modern Pathology (24 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Alexander J. Lazar

426 papers receiving 20.8k citations

Hit Papers

7 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2020 Histopathology
2018 Journal of Clinical Oncology
2017 CA A Cancer Journal for Clinicians
2017 Modern Pathology
2012 Elsevier eBooks
2012 Modern Pathology
2011 Cancer

Peers

Countries citing papers authored by Alexander J. Lazar

Since Specialization

Citations

This map shows the geographic impact of Alexander J. Lazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander J. Lazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander J. Lazar more than expected).

Fields of papers citing papers by Alexander J. Lazar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander J. Lazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander J. Lazar. The network helps show where Alexander J. Lazar may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alexander J. Lazar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alexander J. Lazar Line = papers co-authored together Alexander J. Lazar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	TRPS1 expression in MPNST is correlated with PRC2 inactivation and loss of H3K27me3 Human Pathology ·Rossana Lazcano,Davis R. Ingram,Gauri Panse,Alexander J. Lazar,Pramod Bapna,Jeffrey M. Cloutier	2024	0
2	Analysis of HSP27 and the Autophagy Marker LC3B+ Puncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma Patients Molecular Cancer Therapeutics ·J. Andrew Livingston,Wei‐Lien Wang,Jen-Wei Tsai,Alexander J. Lazar,Cheuk Hong Leung,Heather Lin,Shailesh Advani,Najat C. Daw,N M Ghabel,Волошко Мария Олеговна,Nancy Gordon,Eugenie S. Kleinerman	2018	15
3	Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival Clinical Cancer Research ·Vivek Subbiah,Salah-Eddine Lamhamedi-Cherradi,Branko Cuglievan,Brian A. Menegaz,Cecília Margarita Rendeiro Do Carmo,Winston W. Huh,Vandhana Ramamoorthy,Pete Anderson,Raphael E. Pollock,Dina Lev,Wei Qiao,Mary Frances McAleer,Robert S. Benjamin,Shreyaskumar Patel,Cynthia E. Herzog,Najat C. Daw,Barry W. Feig,Alexander J. Lazar,Andrea Hayes‐Jordan,Joseph A. Ludwig	2018	61
4	NF1+/− Hematopoietic Cells Accelerate Malignant Peripheral Nerve Sheath Tumor Development without Altering Chemotherapy Response Cancer Research ·Rebecca D. Dodd,Chang‐Lung Lee,Paul S. Wolfish,Wesley Huang,William C. Eward,Lixia Luo,Yan Ma,Davis R. Ingram,Keila E. Torres,Diana M. Cardona,Alexander J. Lazar,David G. Kirsch	2017	21
5	Hotspot Mutation Panel Testing Reveals Clonal Evolution in a Study of 265 Paired Primary and Metastatic Tumors Clinical Cancer Research ·Rashmi S. Goswami,Keyur P. Patel,Rajesh R. Singh,Funda Meric‐Bernstam,Scott Kopetz,Vivek Subbiah,Ricardo H. Álvarez,Michael A. Davies,Kausar J. Jabbar,Sinchita Roy‐Chowdhuri,Alexander J. Lazar,L. Jeffrey Medeiros,Russell R. Broaddus,Rajyalakshmi Luthra,Mark J. Routbort	2015	59
6	Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target Clinical Cancer Research ·Guo Chen,Nitin Chakravarti,Kimberly Aardalen,Alexander J. Lazar,Michael T. Tetzlaff,Bradley Wubbenhorst,Sang-Bae Kim,Scott Kopetz,Alicia A. Ledoux,Y.N. Vashisht Gopal,Cristiano Gonçalves Pereira,Wanleng Deng,Ju‐Seog Lee,Katherine L. Nathanson,Kenneth Aldape,Víctor G. Prieto,Darrin D. Stuart,Michael A. Davies	2014	120
7	Complete Loss of PTEN Protein Expression Correlates with Shorter Time to Brain Metastasis and Survival in Stage IIIB/C Melanoma Patients with BRAF V600 Mutations Clinical Cancer Research ·Amanda D. Bucheit,Guo Chen,Alan Siroy,Michael T. Tetzlaff,Russell R. Broaddus,Denái R. Milton,Patricia S. Fox,Roland L. Bassett,Patrick Hwu,Jeffrey E. Gershenwald,Alexander J. Lazar,Michael A. Davies	2014	109
8	Targeting the PI3K/mTOR Axis, Alone and in Combination with Autophagy Blockade, for the Treatment of Malignant Peripheral Nerve Sheath Tumors Molecular Cancer Therapeutics ·Markus P. Ghadimi,Gonzalo Lopez,Keila E. Torres,Roman Belousov,Eric D. Young,Jeffery Liu,Kari J. Brewer Savannah,Aviad Hoffman,Kristelle Lusby,Alexander J. Lazar,Raphael E. Pollock,Dina Lev	2012	42
9	Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma Clinical Cancer Research ·Michael A. Davies,Patricia S. Fox,Nicholas E. Papadopoulos,Agop Y. Bedikian,Wen-Jen Hwu,Alexander J. Lazar,Víctor G. Prieto,Kirk S. Culotta,Timothy Madden,Quanyun A. Xu,Sha Huang,Wanleng Deng,Chaan S. Ng,Sanjay Gupta,Wenbin Liu,Janet Dancey,James R. Wright,Roland L. Bassett,Patrick Hwu,Kevin B. Kim	2012	39
10	MiR-155 Is a Liposarcoma Oncogene That Targets Casein Kinase-1α and Enhances β-Catenin Signaling Cancer Research ·Pingyu Zhang,Katelynn Bill,Juehui Liu,Eric D. Young,Tingsheng Peng,Svetlana Bolshakov,Aviad Hoffman,Yuexi Ren,Elizabeth G. Demicco,Dr.Mohsen Mousa,Chad J. Creighton,Matthew L. Anderson,Alexander J. Lazar,上田英梨子,Raphael E. Pollock,Dina Lev	2012	100
11	Ikk4a/Arf Inactivation with Activation of the NF-κB/IL-6 Pathway Is Sufficient to Drive the Development and Growth of Angiosarcoma Cancer Research ·Jinming Yang,Sara Kantrow,Jiqing Sai,Oriana E. Hawkins,Mark Boothby,Gregory D. Ayers,Eric D. Young,Elizabeth G. Demicco,Alexander J. Lazar,Dina Lev,Ann Richmond	2012	30
12	Survivin Is a Viable Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors Clinical Cancer Research ·Markus P. Ghadimi,Eric D. Young,Roman Belousov,Yiqun Zhang,Gonzalo Lopez,Kristelle Lusby,JM Rash,Elizabeth G. Demicco,Chad J. Creighton,Alexander J. Lazar,Raphael E. Pollock,Dina Lev	2012	36
13	Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma Clinical Cancer Research ·Kari J. Brewer Savannah,Elizabeth G. Demicco,Kristelle Lusby,隆之長沼,Roman Belousov,Eric D. Young,Yiqun Zhang,Kai-Lieh Huang,Alexander J. Lazar,Kelly K. Hunt,Raphael E. Pollock,Chad J. Creighton,Matthew L. Anderson,Dina Lev	2012	40
14	Combining EGFR and mTOR Blockade for the Treatment of Epithelioid Sarcoma Clinical Cancer Research ·Xianbiao Xie,Markus P. Ghadimi,Eric D. Young,Roman Belousov,Quan-Sheng Zhu,Juehui Liu,D. Borchers,Chiara Colombo,Tingsheng Peng,David Reynoso,Jason L. Hornick,Alexander J. Lazar,Dina Lev	2011	34
15	Activated MET Is a Molecular Prognosticator and Potential Therapeutic Target for Malignant Peripheral Nerve Sheath Tumors Clinical Cancer Research ·Keila E. Torres,Quansheng Zhu,Katelynn Bill,Gonzalo López,Markus P. Ghadimi,Xianbiao Xie,Eric D. Young,Juehui Liu,Theresa Nguyen,Svetlana Bolshakov,Roman Belousov,Robert R. Dourmashiin,Guy Lahat,Jun Li,Belinda Hernandez,Alexander J. Lazar,Dina Lev	2011	74
16	Autophagic Survival in Resistance to Histone Deacetylase Inhibitors: Novel Strategies to Treat Malignant Peripheral Nerve Sheath Tumors Cancer Research ·D. Borchers,Keila E. Torres,Juehui Liu,Belinda Hernandez,Eric D. Young,Roman Belousov,Svetlana Bolshakov,Alexander J. Lazar,John M. Slopis,Ian E. McCutcheon,David J. McConkey,Dina Lev	2010	64
17	Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates Molecular Cancer Therapeutics ·Scott E. Woodman,Jonathan C. Trent,Katherine Stemke‐Hale,Alexander J. Lazar,Sabrina Pricl,Giovanni M. Pavan,Maurizio Fermeglia,Y.N. Vashisht Gopal,Dan Yang,Donald A. Podoloff,Doina Ivan,Kevin B. Kim,Nikolaos G. Papadopoulos,Patrick Hwu,Gordon B. Mills,Michael A. Davies	2009	141
18	Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma Clinical Cancer Research ·Michael A. Davies,Katherine Stemke‐Hale,E. Lin,Carmen S. Tellez,Wanleng Deng,Y.N. Vashisht Gopal,Scott E. Woodman,Tiffany L. Calderone,Zhenlin Ju,Alexander J. Lazar,Víctor G. Prieto,Kenneth Aldape,Gordon B. Mills,Jeffrey E. Gershenwald	2009	159
19	Epidermal Growth Factor Receptor Blockade in Combination with Conventional Chemotherapy Inhibits Soft Tissue Sarcoma Cell Growth In vitro and In vivo Clinical Cancer Research ·Wenhong Ren,Borys Korchin,Quansheng Zhu,Caimiao Wei,Adam P. Dicker,John V. Heymach,Alexander J. Lazar,Raphael E. Pollock,Dina Lev	2008	33
20	Association of Intratumoral Vascular Endothelial Growth Factor Expression and Clinical Outcome for Patients with Gastrointestinal Stromal Tumors Treated with Imatinib Mesylate Clinical Cancer Research ·John C. McAuliffe,Alexander J. Lazar,Dan Yang,بهمن صحنه,Wei Qiao,Peter F. Thall,A. Kevin Raymond,Robert S. Benjamin,Jonathan C. Trent	2007	33

About Alexander J. Lazar

Alexander J. Lazar is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Gastroenterology, having authored 448 papers that have together received 21.1k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (225 papers), Vascular Tumors and Angiosarcomas (61 papers), Cardiac tumors and thrombi (56 papers), Cancer Genomics and Diagnostics (49 papers), Soft tissue tumor case studies (48 papers), Melanoma and MAPK Pathways (40 papers), Cutaneous Melanoma Detection and Management (38 papers) and Gastrointestinal Tumor Research and Treatment (34 papers). The work is most often cited by research in Oncology (8.9k citations), Pulmonary and Respiratory Medicine (9.2k citations) and Rheumatology (4.0k citations). Alexander J. Lazar has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Dina Lev, Wei‐Lien Wang, Raphael E. Pollock, Dolores López‐Terrada, Jeffrey E. Gershenwald, Elizabeth G. Demicco, Michael A. Davies, Víctor G. Prieto, Guy Lahat and Eduardo Calonje. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Modern Pathology, Journal of Cutaneous Pathology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact